Cargando…

Experimental Systems for Measuring HIV Latency and Reactivation

The final obstacle to achieving a cure to HIV/AIDS is the presence of latent HIV reservoirs scattered throughout the body. Although antiretroviral therapy maintains plasma viral loads below the levels of detection, upon cessation of therapy, the latent reservoir immediately produces infectious proge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujinaga, Koh, Cary, Daniele C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696534/ https://www.ncbi.nlm.nih.gov/pubmed/33182414 http://dx.doi.org/10.3390/v12111279

Ejemplares similares

Euphorbia Kansui Reactivates Latent HIV
por: Cary, Daniele C., et al.
Publicado: (2016)

Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
por: Pasternak, Alexander O., et al.
Publicado: (2023)

Corrigendum: Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
por: Pasternak, Alexander O., et al.
Publicado: (2023)

β-catenin regulates HIV latency and modulates HIV reactivation
por: Barbian, Hannah J., et al.
Publicado: (2022)

Regulation of KSHV Latency and Lytic Reactivation
por: Broussard, Grant, et al.
Publicado: (2020)

Fused in sarcoma silences HIV gene transcription and maintains viral latency through suppressing AFF4 gene activation
por: Krasnopolsky, Simona, et al.
Publicado: (2019)

HIV-1 Latency and Latency Reversal: Does Subtype Matter?
por: Sarabia, Indra, et al.
Publicado: (2019)

Combinatorial Use of Both Epigenetic and Non-Epigenetic Mechanisms to Efficiently Reactivate HIV Latency
por: Hokello, Joseph, et al.
Publicado: (2021)

HEXIM1-Tat chimera inhibits HIV-1 replication
por: Leoz, Marie, et al.
Publicado: (2018)

Latency, Integration, and Reactivation of Human Herpesvirus-6
por: Pantry, Shara N., et al.
Publicado: (2017)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
por: Lewis, Catherine A., et al.
Publicado: (2023)

CpG Methylation Controls Reactivation of HIV from Latency
por: Blazkova, Jana, et al.
Publicado: (2009)

CpG methylation controls reactivation of HIV from latency
por: Blazkova, Jana, et al.
Publicado: (2010)

Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy?
por: Salahong, Thanarat, et al.
Publicado: (2021)

Nucleolar protein NOP2/NSUN1 suppresses HIV-1 transcription and promotes viral latency by competing with Tat for TAR binding and methylation
por: Kong, Weili, et al.
Publicado: (2020)

Targeting and Understanding HIV Latency: The CRISPR System against the Provirus
por: Magro, Gloria, et al.
Publicado: (2021)

Regulation of the MIE Locus During HCMV Latency and Reactivation
por: Dooley, Abigail L., et al.
Publicado: (2020)

Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation
por: Collins-McMillen, Donna, et al.
Publicado: (2018)

Regulation of Latency and Reactivation by Human Cytomegalovirus miRNAs
por: Diggins, Nicole L., et al.
Publicado: (2021)

Modulation of host cell signaling during cytomegalovirus latency and reactivation
por: Smith, Nicholas A., et al.
Publicado: (2021)

Advances in Model Systems for Human Cytomegalovirus Latency and Reactivation
por: Crawford, Lindsey B., et al.
Publicado: (2022)

Chromatin, gene silencing and HIV latency
por: Mok, Hoi-Ping, et al.
Publicado: (2007)

Latency: the hidden HIV-1 challenge
por: Marcello, Alessandro
Publicado: (2006)

HIV-1 Latency in Monocytes/Macrophages
por: Kumar, Amit, et al.
Publicado: (2014)

HIV-1 transcription and latency: an update
por: Van Lint, Carine, et al.
Publicado: (2013)

Insights into the HIV Latency and the Role of Cytokines
por: Hokello, Joseph, et al.
Publicado: (2019)

A transient heritable memory regulates HIV reactivation from latency
por: Lu, Yiyang, et al.
Publicado: (2021)

The nonequilibrium mechanism of noise-enhanced drug synergy in HIV latency reactivation
por: Guo, Xiaolu, et al.
Publicado: (2022)

HIV Tat/P-TEFb Interaction: A Potential Target for Novel Anti-HIV Therapies
por: Asamitsu, Kaori, et al.
Publicado: (2018)

Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation
por: Ye, Fengchun, et al.
Publicado: (2011)

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression
por: Darcis, Gilles, et al.
Publicado: (2015)

EBV Reactivation from Latency Is a Degrading Experience for the Host
por: Casco, Alejandro, et al.
Publicado: (2023)

Molecular Understanding of HIV-1 Latency
por: Abbas, W., et al.
Publicado: (2012)

The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review
por: Debrabander, Quinten, et al.
Publicado: (2023)

Herpesviruses: latency and reactivation – viral strategies and host response
por: Grinde, Bjørn
Publicado: (2013)

Dynamics of HIV Latency and Reactivation in a Primary CD4+ T Cell Model
por: Mohammadi, Pejman, et al.
Publicado: (2014)

RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency
por: Méndez, Catalina, et al.
Publicado: (2018)

Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui
por: Wang, Pengfei, et al.
Publicado: (2017)

Chromatin Regulation and the Histone Code in HIV Latency 
por: Turner, Anne-Marie W., et al.
Publicado: (2017)

The role of latency reversal in HIV cure strategies
por: Tanaka, Kiho, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_37qbb92e4rpgnsm3hvo8qsrl7m